Financial Ratios

RAJNISH WELLNESS LTD.

NSE : NABSE : 541601ISIN CODE : INE685Z01033Industry : Pharmaceuticals & DrugsHouse : Private
BSE6.49-0.14 (-2.11 %)
PREV CLOSE ( ) 6.63
OPEN PRICE ( ) 6.75
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 3787389
TODAY'S LOW / HIGH ( )6.35 6.83
52 WK LOW / HIGH ( ) 5.7617.9
NSE
This Company is not listed in NSE
Select year
ParticularsMar2023Mar2022Mar2021Mar2020Mar2019
Operational & Financial Ratios
   Earnings Per Share (Rs)0.010.370.21-1.309.06
   CEPS(Rs)0.010.010.00-0.020.14
   DPS(Rs)0.000.000.000.000.00
   Book NAV/Share(Rs)1.0821.0446.4946.2847.58
   Tax Rate(%)27.2528.5813.681.3127.86
Margin Ratios
   Core EBITDA Margin(%)-4.30-0.36-23.730.9815.64
   EBIT Margin(%)2.593.153.141.9816.20
   Pre Tax Margin(%)2.452.080.87-4.4914.09
   PAT Margin (%)1.781.480.75-4.4310.16
   Cash Profit Margin (%)1.831.511.16-4.0410.32
Performance Ratios
   ROA(%)0.691.130.29-1.8817.18
   ROE(%)0.881.790.46-2.7829.97
   ROCE(%)1.082.711.400.9736.75
   Asset Turnover(x)0.390.760.390.421.69
   Sales/Fixed Asset(x)89.27102.0754.6056.54202.06
   Working Capital/Sales(x)0.950.930.500.521.86
Efficiency Ratios
   Fixed Capital/Sales(x)0.010.010.020.020.00
   Receivable days257.12227.79393.83407.72141.95
   Inventory Days41.2922.0629.2352.8122.17
   Payable days36.4824.5039.8451.6867.79
Valuation Parameters
   PER(x)2766.677.500.780.000.24
   PCE(x)2699.26221.4333.86-15.6816.19
   Price/Book(x)15.373.990.240.403.13
   Yield(%)0.000.000.000.000.00
   EV/Net Sales(x)49.783.641.031.191.75
   EV/Core EBITDA(x)1884.64114.6628.9050.3010.68
   EV/EBIT(x)1919.82115.5132.7360.0910.78
   EV/CE(x)13.002.750.400.492.29
   M Cap / Sales49.393.340.390.631.67
Growth Ratio
   Net Sales Growth(%)-2.3198.16-2.95-67.0151.54
   Core EBITDA Growth(%)-18.7676.8046.14-95.2353.02
   EBIT Growth(%)-19.6598.7654.14-95.9753.39
   PAT Growth(%)17.37293.18116.38-114.3774.00
   EPS Growth(%)-98.3974.75116.38-114.3727.04
Financial Stability Ratios
   Total Debt/Equity(x)0.120.410.400.360.21
   Current Ratio(x)3.585.814.905.483.51
   Quick Ratio(x)3.225.464.745.303.18
   Interest Cover(x)18.002.931.380.317.69
   Total Debt/Mcap(x)0.010.101.640.880.07

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.